# Vion Pharmaceuticals clinical trials: 20 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials with Vion Pharmaceuticals as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Vion Pharmaceuticals: 20 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/vion-pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 20, 2006 | NCT00354276 | VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia | Vion Pharmaceuticals | Phase 2 | Unknown | Leukemia | 85 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00354276) |
| March 17, 2006 | NCT00304005 | VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative... | Vion Pharmaceuticals | Phase 1/2 | Completed | Leukemia, Lymphoma | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00304005) |
| January 25, 2006 | NCT00282022 | VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer | Vion Pharmaceuticals | Phase 2 | Completed | Lung Cancer | 87 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00282022) |
| June 3, 2005 | NCT00112554 | Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia | Vion Pharmaceuticals | Phase 3 | Completed | Leukemia | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00112554) |
| December 8, 2004 | NCT00098436 | Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias | Vion Pharmaceuticals | Phase 1 | Completed | Leukemia | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00098436) |
| May 17, 2004 | NCT00083187 | VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia | Vion Pharmaceuticals | Phase 2 | Completed | Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00083187) |
| May 3, 2004 | NCT00004213 | 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors | Vion Pharmaceuticals | Phase 1 | Completed | Unspecified Adult Solid Tumor, Protocol Specific | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00004213) |
| March 17, 2004 | NCT00006218 | 3-AP in Treating Patients With Advanced Cancer | Vion Pharmaceuticals | Phase 1 | Completed | Unspecified Adult Solid Tumor, Protocol Specific | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00006218) |
| February 25, 2004 | NCT00004216 | VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy | Vion Pharmaceuticals | Phase 1 | Completed | Unspecified Adult Solid Tumor, Protocol Specific | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00004216) |
| October 7, 2003 | NCT00070538 | VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies | Vion Pharmaceuticals | Phase 1 | Completed | Leukemia, Myelodysplastic Syndromes | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00070538) |
| September 9, 2003 | NCT00016874 | 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer | Vion Pharmaceuticals | Phase 1 | Completed | Unspecified Adult Solid Tumor, Protocol Specific | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00016874) |
| September 3, 2003 | NCT00006254 | VNP20009 in Treating Patients With Advanced Solid Tumors | Vion Pharmaceuticals | Phase 1 | Completed | Unspecified Adult Solid Tumor, Protocol Specific | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00006254) |
| July 9, 2003 | NCT00064090 | 3-AP and Cytarabine in Treating Patients With Hematologic Cancer | Vion Pharmaceuticals | Phase 1 | Completed | Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00064090) |
| July 9, 2003 | NCT00064064 | 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer | Vion Pharmaceuticals | Phase 2 | Completed | Lung Cancer | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00064064) |
| July 9, 2003 | NCT00064051 | 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | Vion Pharmaceuticals | Phase 2 | Completed | Pancreatic Cancer | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00064051) |
| June 20, 2003 | NCT00024323 | Combination Chemotherapy in Treating Patients With Advanced Cancer | Vion Pharmaceuticals | Phase 1 | Completed | Unspecified Adult Solid Tumor, Protocol Specific | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00024323) |
| February 6, 2003 | NCT00054015 | 3-AP in Treating Patients With Advanced Prostate Cancer | Vion Pharmaceuticals | Phase 2 | Completed | Prostate Cancer | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00054015) |
| January 27, 2003 | NCT00049699 | VNP40101M in Treating Patients With Advanced or Metastatic Cancer | Vion Pharmaceuticals | Phase 1 | Completed | Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00049699) |
| January 27, 2003 | NCT00049686 | VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome | Vion Pharmaceuticals | Phase 1 | Completed | Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00049686) |
| January 27, 2003 | NCT00025129 | VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas | Vion Pharmaceuticals | Phase 1 | Completed | Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00025129) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 12 |
| Phase 1/2 | 1 |
| Phase 2 | 6 |
| Phase 3 | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 19 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Leukemia | 8 |
| Leukemia, Myeloid, Acute | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Congenital Abnormalities | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Myelodysplastic Syndromes | 4 |
| Leukemia, Myelomonocytic, Chronic | 4 |
| Lymphoma | 3 |
| Hodgkin Disease | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Blast Crisis | 3 |
| Anemia, Refractory, with Excess of Blasts | 3 |
| Myelodysplastic-Myeloproliferative Diseases | 3 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3 |
| Myeloproliferative Disorders | 3 |
| Lymphoma, T-Cell, Cutaneous | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Lymphoma, Large-Cell, Immunoblastic | 2 |
| Burkitt Lymphoma | 2 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Intraocular Lymphoma | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Immunoblastic Lymphadenopathy | 2 |
| Lymphoma, Large-Cell, Anaplastic | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Flooring contractors in the United States](https://specstream.ai/data/businesses/flooring-contractors/united-states)
- [Indonesian restaurants in the United States](https://specstream.ai/data/businesses/indonesian-restaurants/united-states)
- [Mediterranean restaurants in the United States](https://specstream.ai/data/businesses/mediterranean-restaurants/united-states)
- [Plastic and reconstructive surgery practices in the United States](https://specstream.ai/data/businesses/plastic-and-reconstructive-surgery-practices/united-states)
- [Sheet metal fabricators in the United States](https://specstream.ai/data/businesses/sheet-metal-fabricators/united-states)
